Skip to content

Investigation of the efficacy of desensitizing effects of bioactive glass-incorporated universal dentin adhesives: a split-mouth model clinical trial

Investigation of the efficacy of desensitizing effects of bioactive glass-incorporated universal dentin adhesives: a split-mouth model clinical trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008101
Enrollment
40
Registered
2023-01-12
Start date
2022-11-23
Completion date
Unknown
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Two groups (experimental group or control group) are randomly assigned to two or more quadrants of the selected subjects. After randomly pre-allocating what kind of sanctions to apply
Hi-bond universal (Mediclus Co., Ltd.) (2) Group MS: resin-based agents for hypersensitivity
MS Coat One (ChoKwang dental)

Sponsors

Kyung Hee University Dental Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The selection criteria are as follows. (1) Adult men and women over the age of 19 with permanent teeth (2) Those who meet the criteria 1 or 2 of the American Society of Anesthesiologists (ASA) (3) Those who have consented to participate in the clinical trial and voluntarily consented in writing (4) Subjects with exposed root surfaces showing hypersensitivity to 50g force probing and air test through clinical examination or teeth showing cervical abrasion exist in two or more quadrants - The tooth must be free from lesions such as dental caries, defective restorations, or fractured teeth. - The tooth must have no apical lesions. - The tooth must not have received any treatment that may cause postoperative hypersensitivity, such as restoration, periodontal surgery, orthodontic treatment, within 3 months.

Exclusion criteria

Exclusion criteria: The exclusion criteria are as follows. (1) Persons with a history of hypersensitivity to quasi-drugs for clinical trials or drugs of the same class (2) Those who received hypersensitivity treatment within 3 months from the date of participation in the clinical trial (3) Those who regularly take antibiotics and painkillers due to medical history (4) Pregnant and lactating women (5) those with a disease that can increase the acidity of the oral cavity; Anorexia, reflux esophagitis, etc. (6) Consuming excessively acidic foods or beverages; Lemon or tomato more than 2 times/day, acidic beverage (sports drink, energy drink, fruit juice) more than 1L/day (7) Those who have difficulty in reading and understanding the instructions provided by clinical research (8) Persons judged to be inappropriate to participate in clinical trials by other investigators

Design outcomes

Primary

MeasureTime frame
Schiff cold air sensitivity scale

Secondary

MeasureTime frame
visual analog scale

Countries

Korea, Republic of

Contacts

Public ContactHyun-Jung Kim

Kyung Hee University Dental Hospital

kimhyunjung@khu.ac.kr+82-2-958-9330

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026